The significance of the study into autoimmune responses being carried out by Cellmid seems to be escaping everyones attention.
They wont be doing that to pass the time waiting for Evolis sales to pick up again.
They have set up a lab and employed people to run it
If they have managed to get a couple of hundred people interested in partaking in the study it wont take long to get through those test kits.
I look on them as an asset and part of inventory that is being utilized.
Why would they be doing that, one asks?
I suspect they may be looking into using MK and/or Covid antibodies as a possible solution to the problem of Covid 19, cytokine storm and lung fibrosis.
With the study they will have both types of antibodies available to them.
- Forums
- ASX - By Stock
- AN1
- present valuation achievable?
present valuation achievable?, page-41
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable